Three Repurposed Drugs Flop for Thwarting Severe COVID

(MedPage Today) -- Early treatment with three repurposed drugs--metformin, ivermectin, or fluvoxamine--did not prevent severe outcomes from COVID-19 in high-risk patients, according to a phase III randomized trial.
Among over 1,300 patients...